DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lurasidone

Lurasidone

  • When Clozapine Is Not Tolerated Mitchell J

    When Clozapine Is Not Tolerated Mitchell J

  • Lurasidone (Latuda) Reference Number: CP.PMN.50 Effective Date: 09.01.15 Last Review Date: 02.21 Line of Business: Commercial, HIM, Medicaid Revision Log

    Lurasidone (Latuda) Reference Number: CP.PMN.50 Effective Date: 09.01.15 Last Review Date: 02.21 Line of Business: Commercial, HIM, Medicaid Revision Log

  • Management of Side Effects of Antipsychotics

    Management of Side Effects of Antipsychotics

  • Lurasidone for Schizophrenia

    Lurasidone for Schizophrenia

  • Weight Changes Before and After Lurasidone Treatment: a Real‑World Analysis Using Electronic Health Records Jonathan M

    Weight Changes Before and After Lurasidone Treatment: a Real‑World Analysis Using Electronic Health Records Jonathan M

  • CT Myelogram Drugs to Avoid Hold for 48 Hours Before and 12 Hours After Your Myelogram UVA Neuroradiology

    CT Myelogram Drugs to Avoid Hold for 48 Hours Before and 12 Hours After Your Myelogram UVA Neuroradiology

  • Clinical Medical & Lurasidone Potentiation of Toxidrome from Drug

    Clinical Medical & Lurasidone Potentiation of Toxidrome from Drug

  • Guideline for Preoperative Medication Management

    Guideline for Preoperative Medication Management

  • Effects of Subchronic Administrations of Vortioxetine, Lurasidone, And

    Effects of Subchronic Administrations of Vortioxetine, Lurasidone, And

  • Pharmacology Review(S)

    Pharmacology Review(S)

  • Psychotropic Drug Indications

    Psychotropic Drug Indications

  • Currently Prescribed Psychotropic Medications

    Currently Prescribed Psychotropic Medications

  • The Effectiveness of Lurasidone Add-On for Residual Aggressive

    The Effectiveness of Lurasidone Add-On for Residual Aggressive

  • Download Leaflet View the Patient Leaflet in PDF Format

    Download Leaflet View the Patient Leaflet in PDF Format

  • Latuda (Lurasidone Hydrochloride) 20 Mg, 40 Mg, 80 Mg, and 120 Mg Tablets

    Latuda (Lurasidone Hydrochloride) 20 Mg, 40 Mg, 80 Mg, and 120 Mg Tablets

  • Is Lurasidone More Safe and Effective in the Treatment Ofschizoaffective Disorder and Schizophrenia Than Other Commonanti-Psychotic Medications? Megan M

    Is Lurasidone More Safe and Effective in the Treatment Ofschizoaffective Disorder and Schizophrenia Than Other Commonanti-Psychotic Medications? Megan M

  • LATUDA Safely and Effectively

    LATUDA Safely and Effectively

  • Antipsychotic Medications Age and Step Therapy

    Antipsychotic Medications Age and Step Therapy

Top View
  • Antipsychotics Therapeutic Class Review (TCR)
  • Heat-Related Illness in Individuals Using Psychiatric Medication 2016
  • Therapeutic Class Overview Atypical Antipsychotics
  • Multi-Target Approach for Drug Discovery Against Schizophrenia
  • Lurasidone Meeting Meeting
  • A Systematic Review of Combination and Volume 1, Issue 1B High-Dose Atypical Antipsychotic Therapy December 2011 in Patients with Schizophrenia
  • Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
  • The Effect of Chronic Treatment with Lurasidone on Rat Liver Cytochrome P450 Expression and Activity in the Chronic Mild Stress Model of Depression
  • Prescribing Information
  • Recommendations for Lab Monitoring of Atypical Antipsychotics
  • Lurasidone (Latuda ) Information Sheet for Gps on Its Use in Bipolar
  • Atypical Antipsychotics
  • Monitoring Adverse Effects of Antipsychotics and Antidepressants: a Population Based Study
  • Clinical Policy: Aripiprazole Long-Acting Injections (Abilify
  • Parenteral Antipsychotics
  • Current Concepts and Treatments of Schizophrenia
  • Lurasidone Injectable Suspension DSP-1349M Clinical Study Protocol D1052024
  • Antipsychotic Update


© 2024 Docslib.org    Feedback